Pharmacists must understand the potential value of biosimilars as a competitive generation of more cost efficient drugs hit the market.
Tina Valbh, BS Pharm, RPh, Axium Healthcare Pharmacy
Advertisement
Articles by Tina Valbh, BS Pharm, RPh, Axium Healthcare Pharmacy
Advertisement
Latest Updated Articles
- The Value Potential of Biosimilars in the United States
February 8th 2016
Advertisement
Advertisement
Trending on Pharmacy Times
1
ADA 2026: Factors Associated With GLP-1 RA Nonresponse in T2D—and What Pharmacists Should Screen For
2
ADA 2026: Earlier GLP-1 and SGLT-2 Use Recommended From Diabetes Diagnosis, Expert Says
3
ADA 2026: Survodutide Cuts Visceral Fat and Normalizes Liver Fat in MASLD. Here's What the Data Mean for Metabolic Risk
4
The Hidden Reimbursement Crisis in Medicare’s Drug Price Negotiation Program
5